A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years

NCT04537793 ·Status: COMPLETED ·Phase: PHASE3

Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation

NCT01262352 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Long-term Safety of VX-445 Combination Therapy

NCT04043806 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)

NCT04599465 ·Status: COMPLETED ·Phase: PHASE3

Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor

NCT07314229 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

NCT03912233 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older

NCT06460506 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age

NCT05882357 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF Genotypes

NCT04545515 ·Status: COMPLETED ·Phase: PHASE3

Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis

NCT03768089 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older

NCT05153317 ·Status: COMPLETED ·Phase: PHASE3

Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function

NCT01685801 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis

NCT03029455 ·Status: COMPLETED ·Phase: PHASE1

Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis.

NCT05599230 ·Status: UNKNOWN

Early Intervention in Cystic Fibrosis Exacerbation

NCT01104402 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation

NCT03068312 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study to Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

NCT02508207 ·Status: COMPLETED ·Phase: PHASE2

Video Telehealth Exercise Training in Cystic Fibrosis

NCT04680403 ·Status: COMPLETED ·Phase: NA

A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

NCT05076149 ·Status: COMPLETED ·Phase: PHASE3

MUCOviscidose EXacerbation Outils Connectés Education Thérapeutique

NCT03304028 ·Status: TERMINATED ·Phase: NA

Remote Sputum Collection in Cystic Fibrosis

NCT06950892 ·Status: RECRUITING

e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population

NCT06313827 ·Status: RECRUITING ·Phase: NA

A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del

NCT04105972 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

NCT03525444 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes

NCT04353817 ·Status: COMPLETED ·Phase: PHASE3